Polypyrimidine tract binding protein induces human papillomavirus type 16 late gene expression by interfering with splicing inhibitory elements at the major late 5′ splice site, SD3632

Journal of Virology

Volumn 82, Issue 7, 2008, Pages 3665-3678

  Somberg, Monika ^a   Zhao, Xiaomin ^a   Fröhlich, Monika ^b   Evander, Magnus ^b   Schwartz, Stefan ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b UMEÅ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; POLYPYRIMIDINE TRACT BINDING PROTEIN; RIBONUCLEOPROTEIN; RIBONUCLEOPROTEIN A2; RIBONUCLEOPROTEIN B1; RIBONUCLEOPROTEIN F; RIBONUCLEOPROTEIN I; RIBONUCLEOPROTEIN Q; UNCLASSIFIED DRUG; VIRUS RNA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION REGULATION; GENE LOCATION; GENE MAPPING; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; RNA SPLICING; VIROGENESIS; VIRUS ACTIVATION; VIRUS GENOME;

BINDING SITES; CELL LINE; GENE EXPRESSION REGULATION, VIRAL; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEIN GROUP A-B; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEIN GROUP F-H; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS; HUMAN PAPILLOMAVIRUS 16; HUMANS; POLYPYRIMIDINE TRACT-BINDING PROTEIN; RNA SPLICE SITES; RNA SPLICING; RNA, VIRAL; SEQUENCE DELETION; TRANSFECTION;

HUMAN PAPILLOMAVIRUS TYPE 16;

EID: 41149123857     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.02140-07     Document Type: Article

References (64)

1. Baker, C., and C. Calef. 1997. Maps of papillomavirus mRNA transcripts. In S. R. Billakanti, C. E. Calef, A. D. Farmer, A. L. Halpern, and G. L. Myers (ed.), Human papillomaviruses: a compilation and analysis of nucleic acid and amino acid sequences. Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Almos, NM.
2. Belsham, G. J., and N. Sonenberg. 1996. RNA-protein interactions in regulation of picornavirus RNA translation. Microbiol. Rev. 60:499-511.
3. Carlsson, A., and S. Schwartz. 2000. Inhibitory activity of the human papillomavirus type 1 AU-rich element correlates inversely with the levels of the elav-like HuR protein in the cell cytoplasm. Arch. Virol. 145:491-503.
4. Cartegni, L., S. L. Chew, and A. R. Krainer. 2002. Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nat. Rev. Genet. 3:285-298.
5. Castelo-Branco, P., A. Furger, M. Wollerton, C. Smith, A. Moreira, and N. J. Proudfoot. 2004. Polypyrimidine tract binding protein modulates efficiency of polyadenylation. Mol. Cell. Biol. 24:4174-4183.
6. Chan, R. C., and D. L. Black. 1997. The polypyrimidine tract binding protein binds upstream of neural cell-specific c-src exon N1 to repress the splicing of the intron downstream. Mol. Cell. Biol. 17:4667-4676.
7. Charlet, B. N., P. Logan, G. Singh, and T. A. Cooper. 2002. Dynamic antagonism between ETR-3 and PTB regulates cell type-specific alternative splicing. Mol. Cell 9:649-658.
8. Cheung, H. C., L. J. Corley, G. N. Fuller, I. E. McCutcheon, and G. J. Cote. 2006. Polypyrimidine tract binding protein and Notch1 are independently re-expressed in glioma. Mod. Pathol. 19:1034-1041.
9. Chou, M. Y., J. G. Underwood, J. Nikolic, M. H. Luu, and D. L. Black. 2000. Multisite RNA binding and release of polypyrimidine tract binding protein during the regulation of c-src neural-specific splicing. Mol. Cell 5:949-957.
10. Collier, B., L. Goobar-Larsson, M. Sokolowski, and S. Schwartz. 1998. Translational inhibition in vitro of human papillomavirus type 16 L2 mRNA mediated through interaction with heterogenous ribonucleoprotein K and poly(rC)-binding proteins 1 and 2. J. Biol. Chem. 273:22648-22656.
11. Collier, B., D. Öberg, X. Zhao, and S. Schwartz. 2002. Specific inactivation of inhibitory sequences in the 5′ end of the human papillomavirus type 16 L1 open reading frame results in production of high levels of L1 protein in human epithelial cells. J. Virol. 76:2739-2752.
12. Cumming, S. A., C. E. Repellin, M. McPhilips, J. C. Redford, J. B. Clements, and S. V. Graham. 2002. The human papillomavirus type 31 untranslated region contains a complex bipartite negative regulatory element. J. Virol. 76:5993-6003.
13. Dirksen, W. P., S. A. Mohamed, and S. A. Fisher. 2003. Splicing of a myosin phosphatase targeting subunit 1 alternative exon is regulated by intronic cis-elements and a novel bipartite exonic enhancer/silencer element. J. Biol. Chem. 278:9722-9732.
14. Doorbar, J. 2005. The papillomavirus life cycle. J. Clin. Virol. 32(Suppl. 1):S7-S15.
15. Dreyfuss, G., V. N. Kim, and N. Kataoka. 2002. Messenger-RNA-binding proteins and the messages they carry. Nat. Rev. Mol. Cell Biol. 3:195-205.
16. Fehrmann, F., and L. A. Laimins. 2003. Human papillomaviruses: targeting differentiating epithelial cells for malignant transformation. Oncogene 22: 5201-5207.
17. Furth, P. A., and C. C. Baker. 1991. An element in the bovine papillomavirus late 3′ untranslated region reduces polyadenylated cytoplasmic RNA levels. J. Virol. 65:5806-5812.
18. Gooding, C., G. C. Roberts, and C. W. Smith. 1998. Role of an inhibitory pyrimidine element and polypyrimidine tract binding protein in repression of a regulated alpha-tropomyosin exon. RNA 4:85-100.
19. Gromak, N., A. Rideau, J. Southby, A. D. Scadden, C. Gooding, S. Huttelmaier, R. H. Singer, and C. W. Smith. 2003. The PTB interacting protein raver1 regulates α-tropomyosin alternative splicing. EMBO J. 22:6356-6364.
20. He, X., M. Pool, K. M. Darcy, S. B. Lim, N. Auersperg, J. S. Coon, and W. T. Beck. 2007. Knockdown of polypyrimidine tract-binding protein suppresses ovarian tumor cell growth and invasiveness in vitro. Oncogene 26:4961-4968.
21. Hebner, C. M., and L. A. Laimins. 2006. Human papillomaviruses: basic mechanisms of pathogenesis and oncogenicity. Rev. Med. Virol. 16:83-97.
22. Howley, P. M., and D. R. Lowy. 2001. Papillomaviridae and their replication, p. 2197-2229. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Virology, vol. 2. Lippincott/The Williams & Wilkins Co., Philadelphia, PA.
23. Huttelmaier, S., S. Illenberger, I. Grosheva, M. Rudiger, R. H. Singer, and B. M. Jockusch. 2001. Raver1, a dual compartment protein, is a ligand for PTB/hnRNPI and microfilament attachment proteins. J. Cell Biol. 155:775-786.
24. Izquierdo, J. M., N. Majos, S. Bonnal, C. Martinez, R. Castelo, R. Guigo, D. Bilbao, and J. Valcarcel. 2005. Regulation of Fas alternative splicing by antagonistic effects of TIA-1 and PTB on exon definition. Mol. Cell 19:475-484.
25. Jeon, S., B. L. Allen-Hoffmann, and P. F. Lambert. 1995. Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells. J. Virol. 69:2989-2997.
26. Jin, Y., H. Suzuki, S. Maegawa, H. Endo, S. Sugano, K. Hashimoto, K. Yasuda, and K. Inoue. 2003. A vertebrate RNA-binding protein Fox-1 regulates tissue-specific splicing via the pentanucleotide GCAUG. EMBO J. 22:905-912.
27. Johansson, C., H. Zhao, E. Bajak, F. Granberg, U. Pettersson, and C. Svensson. 2005. Impact of the interaction between adenovirus E1A and CtBP on host cell gene expression. Virus Res. 113:51-63.
28. Kennedy, I. M., J. K. Haddow, and J. B. Clements. 1990. Analysis of human papillomavirus type 16 late mRNA 3′ processing signals in vitro and in vivo. J. Virol. 64:1825-1829.
29. Kleinhenz, B., M. Fabienke, S. Swiniarski, N. Wittenmayer, J. Kirsch, B. M. Jockusch, H. H. Arnold, and S. Illenberger. 2005. Raver2, a new member of the hnRNP family. FEBS Lett. 579:4254-4258.
30. Le Sommer, C., M. Lesimple, A. Mereau, S. Menoret, M. R. Allo, and S. Hardy. 2005. PTB regulates the processing of a 3′-terminal exon by repressing both splicing and polyadenylation. Mol. Cell. Biol. 25:9595-9607.
31. Li, B., and T. S. Yen. 2002. Characterization of the nuclear export signal of polypyrimidine tract-binding protein. J. Biol. Chem. 277:10306-10314.
32. Lin, C. H., and J. G. Patton. 1995. Regulation of alternative 3′ splice site selection by constitutive splicing factors. RNA 1:234-245.
33. Lin, J. C., and W. Y. Tarn. 2005. Exon selection in α-tropomyosin mRNA is regulated by the antagonistic action of RBM4 and PTB. Mol. Cell. Biol. 25:10111-10121.
34. Lou, H., D. M. Helfman, R. F. Gagel, and S. M. Berget. 1999. Polypyrimidine tract-binding protein positively regulates inclusion of an alternative 3′-terminal exon. Mol. Cell. Biol. 19:78-85.
35. Markovtsov, V., J. M. Nikolic, J. A. Goldman, C. W. Turck, M. Y. Chou, and D. L. Black. 2000. Cooperative assembly of an hnRNP complex induced by a tissue-specific homolog of polypyrimidine tract binding protein. Mol. Cell. Biol. 20:7463-7479.
36. McCutcheon, I. E., S. J. Hentschel, G. N. Fuller, W. Jin, and G. J. Cote. 2004. Expression of the splicing regulator polypyrimidine tract-binding protein in normal and neoplastic brain. Neuro-oncol. 6:9-14.
37. Meyers, C., and L. A. Laimins. 1994. In vitro systems for the study and propagation of human papillomaviruses. Curr. Top. Microbiol. Immunol. 186:199-215.
38. Milligan, S. G., T. Veerapraditsin, B. Ahamet, S. Mole, and S. V. Graham. 2007. Analysis of novel human papillomavirus type 16 late mRNAs in differentiated W12 cervical epithelial cells. Virology 360:172-181.
39. Mole, S., T. Veerapraditsin, M. G. McPhilips, and S. V. Graham. 2006. Regulation of splicing-associated SR proteins by HPV-16. Biochem. Soc. Trans. 34:1145-1147.
40. Nomoto, A., K. Tsukiyama-Kohara, and M. Kohara. 1995. Mechanism of translation initiation on hepatitis C virus RNA. Princess Takamatsu Symp. 25:111-119.
41. Oberg, D., B. Collier, X. Zhao, and S. Schwartz. 2005. A downstream polyadenylation element in human papillomavirus type 16 L2 encodes multiple GGG motifs and interacts with hnRNP H. J. Virol. 79:9254-9269.
42. Oberg, D., B. Collier, X. Zhao, and S. Schwartz. 2003. Mutational inactivation of two distinct negative RNA elements in the human papillomavirus type 16 L2 coding region induces production of high levels of L2 in human cells. J. Virol. 77:11674-11684.
43. Ozbun, M., S. K. Campos, and J. L. Smith. 2007. The early events of human papillomavirus infections: implications for regulation of cell tropism and host range, p. 69-122. In B. Norrild (ed.), Human papillomavirus gene regulation and transformation. Transworld Research Network, Trivandrum, India.
44. Rush, M., X. Zhao, and S. Schwartz. 2005. A splicing enhancer in the E4 coding region of human papillomavirus type 16 is required for early mRNA splicing and polyadenylation as well as inhibition of premature late gene expression. J. Virol. 79:12002-12015.
45. Schwartz, S., M. Somberg, X. Zhao, M. Rush, D. Öberg, H. Cassidy, J. Fay, and H. Lambkin. 2007. Regulation of HPV gene splicing and expression, p. 47-67. In B. Norrild (ed.), Human papillomavirus gene regulation and transformation. Transworld Research Network, Trivandrum, India.
46. Shi, S. T., and M. M. Lai. 2005. Viral and cellular proteins involved in coronavirus replication. Curr. Top. Microbiol. Immunol. 287:95-131.
47. Shukla, S., F. Del Gatto-Konczak, R. Breathnach, and S. A. Fisher. 2005. Competition of PTB with TIA proteins for binding to a U-rich cis-element determines tissue-specific splicing of the myosin phosphatase targeting subunit 1. RNA 11:1725-1736.
48. Sokolowski, M., H. Furneaux, and S. Schwartz. 1999. The inhibitory activity of the AU-rich RNA element in the human papillomavirus type 1 late 3′ untranslated region correlates with its affinity for the elav-like HuR protein. J. Virol. 73:1080-1091.
49. Sokolowski, M., W. Tan, M. Jellne, and S. Schwartz. 1998. mRNA instability elements in the human papillomavirus type 16 L2 coding region. J. Virol. 72:1504-1515.
50. Sokolowski, M., C. Zhao, W. Tan, and S. Schwartz. 1997. AU-rich mRNA instability elements on human papillomavirus type 1 late mRNAs and c-fos mRNAs interact with the same cellular factors. Oncogene 15:2303-2319.
51. Spellman, R., A. Rideau, A. Matlin, C. Gooding, F. Robinson, N. McGlincy, S. N. Grellscheid, J. Southby, M. Wollerton, and C. W. Smith. 2005. Regulation of alternative splicing by PTB and associated factors. Biochem. Soc. Trans. 33:457-460.
52. Spellman, R., and C. W. Smith. 2006. Novel modes of splicing repression by PTB. Trends Biochem. Sci. 31:73-76.
53. Tan, W., B. K. Felber, A. S. Zolotukhin, G. N. Pavlakis, and S. Schwartz. 1995. Efficient expression of the human papillomavirus type 16 L1 protein in epithelial cells by using Rev and the Rev-responsive element of human immunodeficiency virus or the cis-acting transactivation element of simian retrovirus type 1. J. Virol. 69:5607-5620.
54. Tan, W., and S. Schwartz. 1995. The Rev protein of human immunodeficiency virus type 1 counteracts the effect of an AU-rich negative element in the human papillomavirus type 1 late 3′ untranslated region. J. Virol. 69: 2932-2945.
55. Terhune, S. S., C. Milcarek, and L. A. Laimins. 1999. Regulation of human papillomavirus 31 polyadenylation during the differentiation-dependent life cycle. J. Virol. 73:7185-7192.
56. Wiklund, L., M. Sokolowski, A. Carlsson, M. Rush, and S. Schwartz. 2002. Inhibition of translation by UAUUUAU and UAUUUUUAU motifs of the AU-rich RNA instability in the HPV-1 late 3′ untranslated region. J. Biol. Chem. 277:40462-40471.
57. Zang, W. Q., B. Li, P. Y. Huang, M. M. Lai, and T. S. Yen. 2001. Role of polypyrimidine tract binding protein in the function of the hepatitis B virus posttranscriptional regulatory element. J. Virol. 75:10779-10786.
58. Zhao, X., J. Fay, H. Lambkin, and S. Schwartz. 2007. Identification of a 17-nucleotide splicing enhancer in HPV-16 L1 that counteracts the effect of multiple hnRNP A1-binding splicing silencers. Virology 369:351-363.
59. Zhao, X., D. Öberg, M. Rush, J. Fay, H. Lambkin, and S. Schwartz. 2005. A 57-nucleotide upstream early polyadenylation element in human papillomavirus type 16 interacts with hFIP1, CstF-64, hnRNP C1/C2, and polypyrimidine tract binding protein. J. Virol. 79:4270-4288.
60. Zhao, X., M. Rush, A. Carlsson, and S. Schwartz. 2007. The presence of inhibitory RNA elements in the late 3′-untranslated region is a conserved property of human papillomaviruses. Virus Res. 125:135-144.
61. Zhao, X., M. Rush, and S. Schwartz. 2004. Identification of an hnRNP A1-dependent splicing silencer in the human papillomavirus type 16 L1 coding region that prevents premature expression of the late L1 gene. J. Virol. 78:10888-10905.
62. Zheng, Z. M., and C. C. Baker. 2006. Papillomavirus genome structure, expression, and posttranscriptional regulation. Front. Biosci. 11:2286-2302.
63. Zuccato, E., E. Buratti, C. Stuani, F. E. Baralle, and F. Pagani. 2004. An intronic polypyrimidine-rich element downstream of the donor site modulates cystic fibrosis transmembrane conductance regulator exon 9 alternative splicing. J. Biol. Chem. 279:16980-16988.
64. zur Hausen, H. 2002. Papillomaviruses and cancer: from basic studies to clinical application. Nat. Rev. Cancer 2:342-350.